ArticleFrontiers in endocrinology2026
Early-admission serum albumin and hospitalization burden in a selected serial-culture cohort of patients with diabetic foot ulcers and subsequent
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with diabetic foot ulcers (DFUs) who undergo repeat wound culture and subsequent Methods: This single-center retrospective cohort included 408 hospitalized patients with DFU who had a PA-positive wound culture after an earlier non-PA culture during the same admission. Because cohort eligibility required continued hospitalization until repeat sampling and later PA detection, inference was conditional on a post-admission selection event susceptible to immortal-time and collider-selection bias. The culture sequence was an operational ascertainment pattern, not evidence of nosocomial acquisition, microbiological conversion, or invasive PA infection. The co-primary outcomes were length of stay (LOS) and institution-specific nominal hospital charges. Negative binomial and gamma log-link models estimated adjusted within-cohort associations. Exploratory prognostic analyses used bootstrap optimism correction and same-center temporal assessment (development, 2013-2016; assessment, 2017-2018). Results: Among 408 patients [261 men (64.0%)], median LOS was 14 days [interquartile range (IQR), 9-19] and median nominal hospital charges were CNY 18,708 (IQR, 12,532-27,979). Compared with albumin ≥35 g/L, albumin 30 to <35 g/L was associated with longer LOS [adjusted rate ratio (aRR), 1.24; 95% CI, 1.10-1.40] and higher charges [adjusted charge ratio (aCR), 1.28; 95% CI, 1.12-1.46]; corresponding estimates for albumin <30 g/L were 1.52 (95% CI, 1.29-1.78) and 1.67 (95% CI, 1.40-1.99). Per 5-g/L lower albumin, the aRR for LOS was 1.19 (95% CI, 1.14-1.25) and the aCR for charges was 1.22 (95% CI, 1.16-1.28). Baseline-only estimates changed by less than 3% on the log-ratio scale. Adding albumin increased the apparent area under the curve (AUC) from 0.679 to 0.758 (optimism-corrected, 0.643 to 0.729; ΔAUC, 0.079; bootstrap 95% CI, 0.036-0.120). In the same-center temporal assessment sample (126 patients; 50 events), the AUC was 0.592 for the core model and 0.719 after albumin was added; corresponding Brier scores were 0.234 and 0.204, and calibration slopes were 0.625 and 0.994. These small-sample performance estimates were treated as descriptive. The median bootstrap-optimal albumin cutoff was 35 g/L (95% bootstrap percentile interval, 33-37 g/L). Conclusions: Within this selected serial-culture cohort, lower early-admission albumin was associated with greater hospitalization burden and with numerically better exploratory prognostic performance in same-center analyses. These findings do not establish causality, transportability, a diagnosis of malnutrition, or a clinically actionable albumin threshold.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.